Skip to content

$218 Million Verdict – First GMO Trial Against Syngenta

Following a three-week trial, a federal jury in Kansas City, Kansas today ordered Swiss agrochemical giant Syngenta AG to pay $217.7 million in compensatory damages—the entire amount asked for—to a certified class of thousands of Kansas farmers who claimed the company’s genetically modified pest-resistant Viptera seed had been prematurely commercialized before the company secured the […]

June 23, 2017

Farmer inspecting corn maize cobs during harvesting season at field

Following a three-week trial, a federal jury in Kansas City, Kansas today ordered Swiss agrochemical giant Syngenta AG to pay $217.7 million in compensatory damages—the entire amount asked for—to a certified class of thousands of Kansas farmers who claimed the company’s genetically modified pest-resistant Viptera seed had been prematurely commercialized before the company secured the seed trait’s approval from authorities in China, one of the largest importers of U.S. corn.

Syngenta’s aggressive and premature introduction of Viptera resulted in the GMO seed trait’s widespread infiltration into the U.S. corn supply and to China’s 2013 embargo of U.S. corn, causing a sharp drop in corn prices paid to U.S. corn farmers.

About 1.4 million metric tons of U.S. corn were barred, excluding the U.S. almost entirely from the Chinese market, the fastest-growing market in the world. As a result, the average price of U.S. corn dropped by 20% and corn futures plummeted by 15%.

The Basel, Switzerland-based Syngenta, a competitor of Monsanto Co., is currently completing its $43 billion acquisition by the state-owned China National Chemical Corp. It said it intends to appeal the verdict.

The win in the Kansas City, Kansas federal court gives backwind to a host of similar lawsuits against Syngenta by farmers from more than 20 states. Eight statewide classes, including the Kansas class that prevailed today, have already been certified, and there are at least 13 other classes that plaintiffs’ counsel in the centralized federal multidistrict litigation will seek to have the court certify.

Court-appointed Class Counsel Don M. Downing, Patrick J. Stueve, Scott Powell, Bill Chaney and William B. Chaney lead the trial team. Seeger Weiss LLP partners Stephen A. Weiss, who serves on the court-appointed MDL Plaintiffs’ Executive Committee, and Diogenes P. Kekatos have been central to the prosecution of the class plaintiffs’ claims throughout this litigation, including the class certification proceedings, pretrial discovery, and summary judgment motion practice.

Notwithstanding claims relating to this product, the drug/medical device remains approved by the U.S. FDA.

Related News

December 1, 2022
Seeger Weiss now accepting applicants for 2023 Diversity Fellowship

Seeger Weiss LLP announced today that the application period for the firm’s 2023 Diversity Fellowship is now open. Seeger Weiss is committed to providing an inclusive, equitable workplace where team members from all backgrounds can thrive and grow. We believe that diversity makes workplaces, institutions, and our world stronger, smarter, more resilient, and more just. […]

Read More
November 11, 2022
Chris Seeger appointed co-lead counsel in In Re: Social Media Adolescent Addiction/Personal Injury Products Liability Litigation

Seeger Weiss is proud to announce founder Chris Seeger has been appointed to serve as co-lead counsel in the In Re: Social Media Adolescent Addiction/Personal Injury Products Liability Litigation by the honorable Judge Yvonne Gonzalez Rogers. Seeger was one of three lawyers selected to lead the multidistrict litigation pending in the Northern District of California, […]

Read More
November 4, 2022
Seeger Weiss founding partner Chris Seeger helps negotiate $10 billion agreements with Walgreens and CVS in National Prescription Opiate Litigation

Seeger Weiss founding partner Chris Seeger along with partner Jennifer Scullion helped lead the National Prescription Opiate Litigation team in negotiations with Walgreens and CVS that culminated in over $10 billion in settlement agreements to help communities across the country ravaged by the opioid epidemic. In addition to Seeger and Scullion, negotiations were led by […]

Read More